Skip to content

sofosbuvir/velpatasvir

DRUG12 trials

Sponsors

Kirby Institute, Ala'a Sharara, Elizabeth Krans, MD, Brigham and Women's Hospital, Mary E. Keebler, MD

Conditions

A key focus of the study is hepatitis C, but HIV and hepatitis B are also included. The target population includes people who currently use or inject drugs, those with a history of drug use or injection, and their sexual or life partners. People Who Inject Drugs Hepatitis C HIV, Hepatitis BAwaiting Organ TransplantCardiac TransplantHeart TransplantHepatitis CHepatitis C, ChronicKidney TransplantationLiver Transplant

Phase 2

Phase 4

Unknown Phase

Related Papers